| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2874848 | The Annals of Thoracic Surgery | 2013 | 7 Pages |
Abstract
The improvement of cellular immunity against lung cancer depends on both activation and protection of immune cells. The specific inhibition of cancer-expressed FasL is effective in protecting immune cells, thus making FasL a new therapeutic target for cancer treatment.
Keywords
FACSphorbol myristic acetatecontrol siRNAkiloDaltonkDaTCrCTRLFBSMFIDMSOPMAsmall interfering RNAssiRNATumor-infiltrating lymphocytesTILSMinminuteRoom temperatureDimethyl sulfoxideHourfetal bovine serumNumberFas LigandFasLphycoerythrinFlow cytometryMolarmean fluorescent intensitymillimolarNo.Molecular weightcomplete mediumControlT cell receptor
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Yidan MD, PhD, Lunxu MD, PhD, Ting Zhang, Jin PhD,